CSCO – Cisco Systems, Inc is a global firm which builds and delivers IP-based networking solutions related to IT and Communications industry. Its range of products and services include Switching, Next-Generation Network (NGN) Routing, Data Center, Security etc. The stock price was down 2% pre-market today.
CSCO – Cisco Systems, Inc
|Fundamentals||Previously closed at||28.14|
|Analysts opinion||Cisco has a 0.4 Debt-Equity ratio, which is a reasonable debt level. It also has a good 17.42% Return on Equity. Analysts estimate average sales of $49.01 Billion for the current quarter. The consensus rating for the stock is 1.81 which signifies that most analysts have a “Buy” or a “Strong Buy” rating for the stock.|
|However, analysts from Bank of America and Merrill Lynch have downgraded the stock to neutral, and Nomura has reiterated its neutral rating. Also with rivals Brocade and Ruckus merging, the competition for Cisco is getting tougher.|
|Sentiments||Due to the downgrades, there may be short-term bearish sentiments for the stock. However, CSCO may be a good choice for long-term investment.|
|Social Media Pulse||The stock has 0% lower chatter than usual.|
BABY – Natus Medical Inc, is a provider of healthcare services with respect to new-born care and neurology healthcare. The stock had slumped 19% post revision of revenue forecast.
BABY – Natus Medical Inc
|Fundamentals||Previously closed at||31.84|
|Analyst opinion||Natus Medical saw a significant slump in its stock prices post its reporting a lower than forecast preliminary numbers. It estimates a $87.5 Million revenue for Q1 versus the previous forecast of $92.5 million. Another setback may be the lack of payment of $4 million by Venezuela Ministry of health as per the contract. Whether this is just a lack of initial payment that was supposed to arrive in Q4, or a loss of money on the deal is yet to be seen.|
|Sentiments||The investor sentiment for the stock is bearish for the short term.|
|Social Media Pulse||The stock has 100% higher social chatter than usual.|
Disclaimer: This blog contains an aggregated view of analysts and opinions by the author. Do not consider this as financial advice. See http://stockal.com/legalities/